会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • SYSTEM AND METHOD FOR PROPORTIONAL MIXING AND CONTINUOUS DELIVERY OF FLUIDS
    • 用于比例混合和连续输送流体的系统和方法
    • WO2009058647A1
    • 2009-05-07
    • PCT/US2008/080885
    • 2008-10-23
    • MEDRAD, INC.REILLY, David, M.KALAFUT, John, F.SCHRIVER, Ralph, H.
    • REILLY, David, M.KALAFUT, John, F.SCHRIVER, Ralph, H.
    • A61B6/00
    • A61M5/16827A61M5/007A61M5/1422
    • A system and method for mixing and delivering fluids such as contrast media and saline is disclosed including at least two fluid sources, a pump, a joining fluid path connecting the at least two fluid sources to an inlet to the pump, and a valve device in the fluid path upstream of the pump. The valve device includes an actuator adapted to restrict flow in at least one of respective fluid lines connecting the at least two fluid sources to the pump inlet. A patient interface device may be associated with an outlet of the pump. The valve device actuator is generally adapted to restrict the flow in at least one of the respective fluid lines such that an incremental positional change in valve device actuator position provides a substantially linear change in fluid mixture ratio of the fluids from the at least two fluid sources to the pump inlet.
    • 公开了用于混合和输送诸如造影剂和盐水的流体的系统和方法,其包括至少两个流体源,泵,将至少两个流体源连接到泵的入口的连接流体路径,以及将泵装置 泵的上游的流体路径。 阀装置包括致动器,其适于限制在将至少两个流体源连接到泵入口的各个流体管线中的至少一个中的流动。 患者接口装置可以与泵的出口相关联。 阀装置致动器通常适于限制相应流体管线中的至少一个中的流动,使得阀装置致动器位置的增量位置变化提供来自至少两个流体源的流体的流体混合比的基本线性变化 到泵入口。
    • 8. 发明申请
    • MODELING OF PHARMACEUTICAL PROPAGATION AND PARAMETER GENERATION FOR INJECTION PROTOCOLS
    • 药物传播建模与注射方案参数生成
    • WO2011163578A2
    • 2011-12-29
    • PCT/US2011/041802
    • 2011-06-24
    • MEDRAD, INC.KALAFUT, John, F.
    • KALAFUT, John, F.
    • G06F19/00
    • G16H50/50A61B6/507G06F19/00
    • A system includes a parameter generation system to determine at least one parameter for an injection procedure (for example, a parameter of an injection protocol or an imaging system parameter), the parameter generator system includes a physiologically based pharmacokinetic model to model propagation of a contrast medium injected into a patient including at least one of a non-linear saturation term in a peripheral venous compartment, at least one configurable transport delay term through at least one compartment, or an adaptation to model volumetric flow rate of blood and an effect thereof on the propagation of contrast medium after injection of contrast medium ceases. The physiologically based pharmacokinetic model can, for example, be discretizable.
    • 系统包括参数产生系统以确定用于注射过程的至少一个参数(例如,注射方案或成像系统参数的参数),参数发生器系统包括用于模拟对比度的传播的基于生理学的药代动力学模型 包括在外周静脉隔室中的非线性饱和项中的至少一个的介质,至少一个可配置的运输延迟项通过至少一个隔室,或适应于血液的模型容积流量及其效果 注射造影剂后造影剂的传播停止。 基于生理学的药代动力学模型可以例如是可离散的。
    • 9. 发明申请
    • MODELING OF PHARMACEUTICAL PROPAGATION
    • 药物传播建模
    • WO2006055813A2
    • 2006-05-26
    • PCT/US2005/041913
    • 2005-11-16
    • MEDRAD, INC.KALAFUT, John, F.UBER, Arthur, E.
    • KALAFUT, John, F.UBER, Arthur, E.
    • A61M31/00
    • A61M5/007A61B5/0044A61B5/02028A61B5/0205A61B5/026A61B5/029A61B5/0295A61B5/055A61B5/7257A61B6/032A61B6/481A61B6/504A61B6/507A61B6/583A61B8/13A61B8/481A61K49/0002G01R33/5601G06F19/00G06F19/321G06F19/3468G16H50/50
    • A method of delivering a contrast enhancing fluid to a patient using an injector system, including: determining at least one patient transfer function for the patient based upon data specific to the patient, the at least one patient transfer function providing a time enhancement output for a given input; determining a desired time enhancement output; using the at least one patient transfer function to determine an injection procedure input; and controlling the injector system at least in part on the basis of the determined injection procedure input. The injection procedure input can determined considering at least one operational limitation or constraint of the injector system. A method of modeling propagation of a pharmaceutical fluid in a patient, includes: collecting data corresponding to a time response curve resulting from injection of the fluid; and determining at least one mathematical model describing the data. The mathematical model can, for example, be a model which is not determined by a continuous or a discrete-time Fourier deconvolution of the data. A method of controlling injection of a pharmaceutical fluid into a patient using an injector in a medical procedure, includes: collecting data corresponding to a patient response curve resulting from injection of the fluid; determining at least one mathematical model describing the data; and controlling the injector during the medical procedure to control injection of the fluid into the patient to create patient response at least in part on the basis of the mathematical model. A method of controlling injection of a contrast medium into a patient using an injector in a medical imaging procedure using an imaging scanner, includes: determining at least one mathematical model to predict a time enhancement response resulting from injection of the contrast medium; determining an injection protocol to approximate a predetermined time enhancement response in the patient by determining a constrained input solution to the mathematical model; and using the injection protocol to control the injector during the medical imaging procedure to control injection of the contrast medium into the patient to create an image of a region of interest.
    • 一种使用注射器系统将对比度增强流体递送到患者的方法,包括:基于患者特有的数据确定患者的至少一个患者转移功能,所述至少一个患者传递函数为 给定输入; 确定期望的时间增强输出; 使用所述至少一个患者传递函数来确定注射过程输入; 以及至少部分地基于所确定的喷射过程输入来控制喷射器系统。 注射过程输入可以考虑至少一个注射器系统的操作限制或约束来确定。 一种建模患者体内药液传播的方法,包括:收集对应于由注射液体引起的时间响应曲线的数据; 以及确定描述数据的至少一个数学模型。 数学模型可以例如是不是由数据的连续或离散时间傅里叶解卷积决定的模型。 一种在医疗过程中使用注射器控制药物流体注入到患者体内的方法包括:收集对应于由注射流体引起的患者反应曲线的数据; 确定描述数据的至少一个数学模型; 以及在所述医疗过程期间控制所述注射器以控制将流体注射到患者体内,以至少部分地基于所述数学模型产生患者反应。 一种使用成像扫描仪在医疗成像程序中使用注射器将造影剂注射到患者体内的方法包括:确定至少一个数学模型以预测由注射造影剂引起的时间增强响应; 通过确定所述数学模型的约束输入解决方案来确定注射协议以近似所述患者中的预定时间增强响应; 并且在医疗成像过程期间使用注射方案来控制注射器以控制将造影剂注射到患者体内以创建感兴趣区域的图像。